Theriva Biologics Inc (TOVX)
AMEX
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TOVX market cap is 3.84M. The company's latest EPS is USD -3.1334 and P/E is -0.15.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.39M | -8.49M | -7.89M | -4.58M | -4.42M |
| Net Income | -5.17M | -8.32M | -7.73M | -4.45M | -4.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.16M | -14.27M | -21.58M | -21.43M | -26.35M |
| Net Income | -12.56M | -23.19M | -20.03M | -18.35M | -25.65M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 48.73M | 42.39M | 40.11M | 35.35M | 32.16M |
| Total Liabilities | 14.61M | 14.74M | 15.47M | 16.29M | 16.66M |
| Total Equity | 31.39M | 25.9M | 24.64M | 19.07M | 15.5M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.41M | 70.37M | 71.86M | 55.22M | 35.35M |
| Total Liabilities | 3.15M | 4.96M | 17.3M | 15.52M | 16.29M |
| Total Equity | -7.54M | 65.41M | 51.83M | 36.96M | 19.07M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.88M | -8.33M | -12.25M | -16.94M | -4.76M |
| Investing | N/A | -1,000 | -1,000 | -1,000 | N/A |
| Financing | N/A | 1.77M | 5.49M | 5.5M | 3.07M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.17M | -12.89M | -19.08M | -19M | -16.94M |
| Investing | -9k | -14k | -4.4M | -202k | -1,000 |
| Financing | 3.36M | 74M | -1.93M | 625k | 5.5M |
| Market Cap | 3.84M |
| Price to Earnings Ratio | -0.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.34 |
| Price to Book Ratio | 0.21 |
| Dividend Yield | - |
| Shares Outstanding | 8.19M |
| Average Volume (1 week) | 464.35k |
| Average Volume (1 Month) | 1.66M |
| 52 Week Change | -92.14% |
| 52 Week High | 7.3725 |
| 52 Week Low | 0.402 |
| Spread (Intraday) | 0.04 (8.16%) |
| Company Name | Theriva Biologics Inc |
| Address |
9605 medical center drive rockville, maryland 20850 |
| Website | https://www.syntheticbiologics.com |
| Industry | business services (7300) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
